📖
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI – GINECO study
Florence Joly, Michel Fabbro, Philippe Follana, Justine Lequesne, Jacques Medioni, Anne Lesoin, Jean-Sébastien Frenel, Sophie Abadie-Lacourtoisie, Anne Floquet, Laurence Gladieff, Benoît You, Céline Gavoille, Elsa Kalbacher, Mélanie Briand, Pierre-Emmanuel Brachet, Florence Giffard, Louis-Bastien Weiswald, Pierre-Alexandre Just, Cécile Blanc-Fournier, Alexandra Leconte, Bénédicte Clarisse, Alexandra Leary, Laurent Poulain

A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI – GINECO study

Science & Mathematics Published 2022 Verification Pending

Overview & Synopsis

Background: There are limited treatment options for ovarian cancer patients with early relapse after platinum chemotherapy. In preclinical studies, we previously demonstrated the promising activity of ABT-737, a Bcl-2/Bcl-xL anti-apoptotic protein inhibitor, in chemo-resistant ovarian cancer cells and tumors, suggesting its potential activity in platinum-resistant patients. Methods: We conducted a prospective multicenter single-arm phase II study to assess the efficacy of Navitoclax (orally available ABT-737 analogue) monotherapy in 46 heavily pretreated (2-12 lines, median = 4) patients with high-grade serous platinum-resistant ovarian tumors. Navitoclax was administered at the daily dose of 150 mg during a lead-in period (7-14 days) and then increased to 250 mg daily in the absence of dose-limiting thrombocytopenia (

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI – GINECO study
Author / Organization Florence Joly, Michel Fabbro, Philippe Follana, Justine Lequesne, Jacques Medioni, Anne Lesoin, Jean-Sébastien Frenel, Sophie Abadie-Lacourtoisie, Anne Floquet, Laurence Gladieff, Benoît You, Céline Gavoille, Elsa Kalbacher, Mélanie Briand, Pierre-Emmanuel Brachet, Florence Giffard, Louis-Bastien Weiswald, Pierre-Alexandre Just, Cécile Blanc-Fournier, Alexandra Leconte, Bénédicte Clarisse, Alexandra Leary, Laurent Poulain
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2022
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-199769
Original Source Link Visit Source Page on hal.science »